Business Wire

CO-WESTERN-UNION

22.6.2021 12:02:05 CEST | Business Wire | Press release

Share
Western Union Releases 2020 Environmental, Social and Governance (ESG) Report

The Western Union Company (NYSE: WU), a global leader in cross-border, cross-currency money movement and payments, today released its 2020 Environmental, Social and Governance (ESG) Report , spotlighting the company’s commitment to its stakeholders through an evolved ESG strategy and actions aligned to its key ESG priorities.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210622005354/en/

“2020 reinforced the importance of collective action to address global challenges,” said Hikmet Ersek, Western Union’s President and CEO. “Following a year in which borders were sealed and economies struggled, we emerged with an even sharper focus on our role as a connector of people and businesses globally. Our ESG efforts are closely aligned to this view of our business, and our belief that we have a critical role to play in creating solutions and building collaborations worldwide to advance shared ESG priorities.”

2020 ESG Highlights

The report outlines the company’s efforts to connect people and businesses globally, foster an inclusive workplace, move money with integrity, uphold strong governance, safeguard our shared environment, and provide training, education and crisis relief through the Western Union Foundation. Key accomplishments in these areas included:

  • Cross-border money movement : Enabling nearly 150 million customers in more than 200 countries and territories to send and receive funds in more than 130 currencies, to and from almost anywhere, as the global pandemic raged.
  • Support for migrants: Continuing to support migrant, refugee and other vulnerable populations through monetary and other support to organizations focused on these groups, raising awareness and funding critical research.
  • Fraud prevention: Preventing $1.4 billion of fraudulent transactions, with the lowest annual dollar-value payout reported as fraud since Western Union began tracking consumer fraud claims in 2005.
  • Board diversity: Actively ensuring diversity at Board level - as of 2020, 45% of the company’s 11 Board members were female and/or identified as Latinx, Asian or LGBTQ+.
  • Human rights: Identifying and prioritizing the company’s human rights impacts, and releasing a Human Rights Statement guided by internationally recognized standards.
  • Western Union Foundation: Enabling the Western Union Foundation to reach more than 200,000 people through workforce skilling and support for resilience in crises.

Western Union’s ESG Strategy and Goals

In 2020, Western Union completed a refreshed materiality assessment to further shape its ESG strategy and priorities. This process identified 21 ESG topics to be integrated into Western Union’s ESG efforts, prioritizing three topics of greatest importance to its business and stakeholders: furthering economic prosperity around the world ; promoting the integrity of global money movement; and advancing diversity, equity, and inclusion (DEI).

The company also set forth the following goals to continue advancing its ESG priorities:

  • Maintain gender pay equity globally and racial/ethnic pay equity in the U.S.
  • Increase gender diversity in leadership, achieving at least 40% women in senior management positions by 2025.
  • Increase racial and ethnic diversity among employees, including reaching at least 25% Latinx and Black employees in the U.S. by 2025.
  • Conduct more than 300,000 partner engagements, such as compliance program reviews or trainings, with Western Union partners globally to continue building capacity within the financial system to detect and prevent illicit activity, by 2025.
  • Reach approximately 300 million consumers and clients to promote fraud awareness and education by 2025.

The Western Union 2020 ESG report and executive summary are available for download at https://corporate.westernunion.com/esg/ . It is prepared in accordance with Global Reporting Initiative (GRI) standards, and includes responses to select relevant metrics from the Sustainability Accounting Standards Board (SASB) Standards. The report also details Western Union’s actions to advance the United Nations Sustainable Development Goals.

Safe Harbor Compliance Statement for Forward-Looking Statements

This press release contains certain statements that are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. These statements are not historical facts or guarantees of future outcomes, but rather are based on current expectations, estimates, assumptions, and projections, and include statements regarding our goals, commitments, programs, and other plans and objectives. Words such as “expects,” “intends,” “targets,” “goals,” “anticipates,” “believes,” “estimates,” “aims,” “plans,” “strives,” and other similar expressions or future or conditional verbs such as “may,” “will,” “should,” “would,” “could,” and “might” are intended to identify such forward-looking statements. Our actual outcomes and results may differ materially from those expressed in, or implied by, our forward-looking statements based on changes in circumstances, assumptions not being realized, or other risks, uncertainties, and factors. Such risks, uncertainties, and factors include, but are not limited to, those discussed in the Risk Factors section throughout our Annual Report on Form 10-K for the year ended December 31, 2020 and subsequent Quarterly Reports on Form 10-Q and Current Reports filed on Form 8-K with the U.S. Securities and Exchange Commission. In addition, we cannot assure you that outcomes or results, including the achievement of any stated goals or targets, will have the forecasted, desired, or expected consequences and effects. Our forward-looking statements are only as of the date they are made, and we undertake no obligation to update any forward-looking statement.

About Western Union

The Western Union Company (NYSE: WU) is a global leader in cross-border, cross-currency money movement and payments. Western Union’s platform provides seamless cross-border flows and its leading global financial network bridges more than 200 countries and territories and over 130 currencies. We connect businesses, financial institutions, governments, and consumers through one of the world’s widest reaching networks, accessing billions of bank accounts, millions of digital wallets, and cards, and over half a million retail locations. Western Union connects the world to bring boundless possibilities within reach. For more information, visit www.westernunion.com .

WU-G

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye